Merck
CN

RNA replicon delivery via lipid-complexed PRINT protein particles.

Molecular pharmaceutics (2013-08-09)
Jing Xu, J Christopher Luft, Xianwen Yi, Shaomin Tian, Gary Owens, Jin Wang, Ashley Johnson, Peter Berglund, Jonathan Smith, Mary E Napier, Joseph M DeSimone
摘要

Herein we report the development of a nonviral lipid-complexed PRINT (particle replication in nonwetting templates) protein particle system (LPP particle) for RNA replicon delivery with a view toward RNA replicon-based vaccination. Cylindrical bovine serum albumin (BSA) particles (diameter (d) 1 μm, height (h) 1 μm) loaded with RNA replicon and stabilized with a fully reversible disulfide cross-linker were fabricated using PRINT technology. Highly efficient delivery of the particles to Vero cells was achieved by complexing particles with a mixture of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) lipids. Our data suggest that (1) this lipid-complexed protein particle is a promising system for delivery of RNA replicon-based vaccines and (2) it is necessary to use a degradable cross-linker for successful delivery of RNA replicon via protein-based particles.

材料
货号
品牌
产品描述

Avanti
18:1(Δ9-顺式)PE (DOPE), Avanti Polar Lipids
Avanti
18:1 TAP (DOTAP), Avanti Polar Lipids
Avanti
18:1 (Δ9-Cis) PE (DOPE), Avanti Polar Lipids
Avanti
18:1 TAP (DOTAP), Avanti Polar Lipids